NCT01844583View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 25, 2013

Primary Completion Date

August 4, 2014

Study Completion Date

September 6, 2016

Conditions
Solid TumorsLymphoma
Interventions
DRUG

Alisertib

Alisertib tablets

DRUG

Esomeprazole

Esomeprazole capsules

DRUG

Rifampin

Rifampin capsules

Trial Locations (7)

Unknown

Sarasota

St Louis

Oklahoma City

Nashville

Dallas

San Antonio

Madison

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY